Amazon.com Inc
Change company Symbol lookup
Select an option...
AMZN Amazon.com Inc
CLPR Clipper Realty Inc
VGI Virtus Global Multi-Sector Income Fund
VDE Vanguard Energy Index Fund ETF Shares
VCV Invesco California Value Municipal Income Trust
VCSH Vanguard Short-Term Corporate Bond Index Fund ETF Shares
VBR Vanguard Small-Cap Value Index Fund ETF Shares
V Visa Inc
UPS United Parcel Service Inc
UNM Unum Group
Go

Consumer Discretionary : Internet & Direct Marketing Retail | Large Cap Growth
Company profile

Amazon.com, Inc. offers a range of products and services through its Websites. The Company's products include merchandise and content that it purchases for resale from vendors and those offered by third-party sellers. It also manufactures and sells electronic devices. It operates through three segments: North America, International and Amazon Web Services (AWS). Its AWS products include analytics, Amazon Athena, Amazon CloudSearch, Amazon EMR, Amazon Elasticsearch Service, Amazon Kinesis, Amazon Managed Streaming for Apache Kafka, Amazon Redshift, Amazon QuickSight, AWS Data Pipeline, AWS Glue and AWS Lake Formation. AWS solutions include machine learning, analytics and data lakes, Internet of Things, serverless computing, containers, enterprise applications, and storage. In addition, the Company provides services, such as advertising. It also offers Amazon Prime, a membership program that includes free shipping, access to streaming of various movies and television (TV) episodes.

Premarket

Last Trade
Delayed
$2,888.05
9.35 (0.32%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$2,878.70
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
5,953

10-day average volume:
4,274,285
5,953

Evofem stock rallies as FDA approves birth-control gel

4:37 pm ET May 22, 2020 (MarketWatch)
Print

Evofem Biosciences Inc. (EVFM) stock rallied in the extended session Friday after the biotech company said the Food and Drug Administration approved its birth-control gel. Evofem shares surged 23% after hours, following a 3.7% rise to close the regular session at $4.99. The company said the FDA approved Phexxi, a gel that uses lactic acid and citric acid to put vaginal pH levels in the 3.5 to 4.5 range, which is inhospitable to sperm. Evofem said it is working to have Phexxi covered under the Affordable Care Act.

-Wallace Witkowski; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

May 22, 2020 16:37 ET (20:37 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.